Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
Cancer is a complex disease that can originate in virtually all the tissues of the body, and tumors progress through many different stages during their development. While genetic mutations in the emerging cancer cells drive this disease, it has become increasingly clear that cancer development is st...
Main Authors: | DuPage, Michel J., Jacks, Tyler E. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2016
|
Online Access: | http://hdl.handle.net/1721.1/104801 https://orcid.org/0000-0001-5785-8911 |
Similar Items
-
MHC-II neoantigens shape tumour immunity and response to immunotherapy
by: Luoma, Adrienne M., et al.
Published: (2020) -
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
by: DuPage, Michel J., et al.
Published: (2014) -
Investigation of T cell-mediated immune surveillance against tumor-specific antigens in genetically engineered mouse models of cancer
by: Du Page, Michel Justin Porter
Published: (2011) -
Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation
by: Schmidt, Leah Marie, et al.
Published: (2020) -
Expression of tumour-specific antigens underlies cancer immunoediting
by: DuPage, Michel J., et al.
Published: (2012)